Asahi Intecc (7747) Q2 2025 earnings summary

Executive summary

• Revenue for FYE June 2025 Q2 YTD rose 13.2% year-over-year to 61,491 million yen, driven by strong Medical Division performance and favorable exchange rates.

• Operating income increased 28.9% year-over-year to 17,395 million yen, with gross profit margin improving and net income attributable to parent company shareholders up 24.9% to 12,261 million yen.

• Comprehensive income grew 28.9% to 12,501 million yen.

Financial highlights

• Gross profit reached 41,549 million yen, up 18.1% year-over-year.

• EBITDA increased 24.4% year-over-year to 22,710 million yen.

• EPS rose 24.9% year-over-year to 45.14 yen.

• Ordinary income was 16,821 million yen, up 24.9% year-over-year.

• Equity-to-asset ratio improved to 83.2% from 78.9% at the previous fiscal year-end.

Outlook and guidance

• Full-year net sales forecast maintained at 116,737 million yen (up 8.5% year-over-year), with operating profit projected at 25,210 million yen (up 13.9%) and profit attributable to owners of parent at 18,803 million yen (up 18.9%).

• Dividend forecast for the year ending June 30, 2025, is 24.23 yen per share.

• The company is monitoring potential impacts from unauthorized product inflows into China and assessing gross margin and cost factors for the second half.